Igenbio collaborates with scientists and professors in the process of submitting genomics based studies to funding agencies like the NIH and USDA. Our team has a track record of grant success both as PI and as a partner or Co-PI for SBIR, R01 type proposals.

We also partner with biotech start-ups for business proposals that require next generation sequences, genome annotations, reconstructions and other bioinformatics services. We provide letters of support, budget and scientific content to enhance the chances of winning the grant or investment.

Igenbio is the global leader in microbial genomics, with more than 17 years of experience working with governmental organizations like the NIH and USDA. Whether your project calls for the sequencing and annotation of a new organism or the metabolic engineering of an organism that's been sequenced already, Igenbio provides the leading content, analysis software and scientific expertise to help you stay ahead of the competition.

Grants Awarded

  • 2008: Genome based drug discovery: NIH Grant 5U01AI070499-02.
  • 2007 SBIR: Metabolic reconstruction for Butanol production.
  • 2002: Oral microbial Genomics NIH Grant R4GM61431-02.

Related Publications